다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical immunology : the official journal of the Clinical Immunology Society, v.183, 2017년, pp.304 - 315
Grönwall, Caroline (Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Hardt, Uta (Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Gustafsson, Johanna T. (Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Elvin, Kerstin (Department of Clinical Immunology and Transfusion Medicine, Unit of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Jensen-Urstad, Kerstin (Department of Clinical Physiology, Sö) , Kvarnström, Marika (dersjukhuset, Karolinska Institutet, Stockholm, Sweden) , Grosso, Giorgia (Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Rönnelid, Johan (Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden) , Padykov, Leonid (Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden) , Gunnarsson, Iva (Department of Medicine, Rheumatology Unit, Karolinska Insti) , Silverman, Gregg J. , Svenungsson, Elisabet
AI-Helper
Abstract Natural IgM autoantibodies have been proposed to convey protection from autoimmune pathogenesis. Herein, we investigated the IgM responses in 396 systemic lupus erythematosus (SLE) patients, divided into subgroups based on distinct autoantibody profiles. Depressed IgM levels were more comm...
Autoimmun. Rev. Gatto 12 523 2013 10.1016/j.autrev.2012.09.003 Emerging and critical issues in the pathogenesis of lupus
Lancet Lisnevskaia 384 1878 2014 10.1016/S0140-6736(14)60128-8 Systemic lupus erythematosus
Annu. Rev. Immunol. Marshak-Rothstein 25 419 2007 10.1146/annurev.immunol.22.012703.104514 Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease
Lupus Ronnblom 17 394 2008 10.1177/0961203308090020 The innate immune system in SLE: type I interferons and dendritic cells
N. Engl. J. Med. Levine 346 752 2002 10.1056/NEJMra002974 The antiphospholipid syndrome
J. Thromb. Haemost. Miyakis 4 295 2006 10.1111/j.1538-7836.2006.01753.x International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
J. Autoimmun. Pons-Estel 76 10 2017 10.1016/j.jaut.2016.10.004 The antiphospholipid syndrome in patients with systemic lupus erythematosus
Clin. Epidemiol. Patel 6 247 2014 The epidemiology of Sjögren's syndrome
Ann. Rheum. Dis. Vitali 61 554 2002 10.1136/ard.61.6.554 Group on classification criteria for Sjögren's syndrome: a revised version of the european criteria proposed by the American-European consensus group
Nat. Rev. Rheumatol. Munoz 6 280 2010 10.1038/nrrheum.2010.46 The role of defective clearance of apoptotic cells in systemic autoimmunity
Front. Immunol. Grönwall 3 66 2012 10.3389/fimmu.2012.00066 Protective roles of natural IgM antibodies
Nat. Rev. Rheumatol. Silverman 9 291 2013 10.1038/nrrheum.2013.30 Protective autoantibodies in the rheumatic diseases: lessons for therapy
Nat. Rev. Immunol. Baumgarth 11 34 2011 10.1038/nri2901 The double life of a B-1 cell: self-reactivity selects for protective effector functions
Proc. Natl. Acad. Sci. U. S. A. Baumgarth 96 2250 1999 10.1073/pnas.96.5.2250 Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system
J. Clin. Invest. Chou 119 1335 2009 10.1172/JCI36800 Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
Nat. Med. Binder 9 736 2003 10.1038/nm876 Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between streptococcus pneumoniae and oxidized ldl
J. Immunol. Chen 183 1346 2009 10.4049/jimmunol.0900948 Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis
J. Immunol. Chen 182 6031 2009 10.4049/jimmunol.0804191 IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells
Proc. Natl. Acad. Sci. U. S. A. Grönwall 109 19745 2012 10.1073/pnas.1211868109 MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses
Arthritis Rheum. Vas 64 3388 2012 10.1002/art.34537 Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes
Arthritis Res. Ther. Anania 12 R214 2010 10.1186/ar3193 Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
J. Autoimmun. de Faire 34 73 2010 10.1016/j.jaut.2009.05.003 Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism
Stroke Fiskesund 41 607 2010 10.1161/STROKEAHA.109.558742 Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden
Res. Immunol. Fiskesund 2 13 2012 10.1016/j.rinim.2012.01.001 IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL
Clin. Immunol. Grönwall 142 390 2012 10.1016/j.clim.2012.01.002 IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE
Clin. Immunol. Grönwall 153 1 2014 10.1016/j.clim.2014.03.017 Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus
Atherosclerosis Su 188 160 2006 10.1016/j.atherosclerosis.2005.10.017 Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension
Rheumatology (Oxford) Su 47 1144 2008 10.1093/rheumatology/ken120 Natural antibodies against phosphorylcholine as potential protective factors in SLE
Arthritis Rheum. Tan 25 1271 1982 10.1002/art.1780251101 The 1982 revised criteria for the classification of systemic lupus erythematosus
J. Rheumatol. Gladman 29 288 2002 Systemic lupus erythematosus disease activity index 2000
Arthritis Rheum. Gladman 39 363 1996 10.1002/art.1780390303 The development and initial validation of the systemic lupus international collaborating clinics/american college of rheumatology damage index for systemic lupus erythematosus
PLoS One Gustafsson 12 e0174572 2017 10.1371/journal.pone.0174572 Excess atherosclerosis in systemic lupus erythematosus,-a matter of renal involvement: case control study of 281 SLE patients and 281 individually matched population controls
Ann. Rheum. Dis. Kallberg 70 508 2011 10.1136/ard.2009.120899 Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke
Ann. Rheum. Dis. Lundström 72 1018 2013 10.1136/annrheumdis-2012-201760 HLA-DRD1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
Clin. Exp. Immunol. Gonzalez-Quintela 151 42 2008 10.1111/j.1365-2249.2007.03545.x Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities
Genes Immun. Morris 15 210 2014 10.1038/gene.2014.6 Mhc associations with clinical and autoantibody manifestations in european SLE
Clin. Rheumatol. Ruiz-Larranaga 35 1161 2016 10.1007/s10067-016-3235-8 Genetic association study of systemic lupus erythematosus and disease subphenotypes in European populations
Arthritis Rheum. Esdaile 44 2331 2001 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I Traditional framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
Am. J. Epidemiol. Manzi 145 408 1997 10.1093/oxfordjournals.aje.a009122 Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the framingham study
Arthritis Res. Ther. Gustafsson 11 R186 2009 10.1186/ar2878 Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
J. Autoimmun. Grönwall 73 30 2016 10.1016/j.jaut.2016.05.014 Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity
J. Autoimmun. Grönwall 2017 10.1016/j.jaut.2017.06.004 Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis
J. Immunol. Shaw 170 6151 2003 10.4049/jimmunol.170.12.6151 The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells
J. Immunol. Fiskesund 192 4551 2014 10.4049/jimmunol.1303035 Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult
Lupus Gunti 24 1567 2015 10.1177/0961203315603144 Polyreactive antibodies in the circulation of patients with systemic lupus erythematosus
J. Immunol. Holodick 196 4348 2016 10.4049/jimmunol.1600073 Age-related decline in natural IgM function: diversification and selection of the B-1a cell pool with age
Nutr. Metab. (Lond.) Frostegård 4 7 2007 10.1186/1743-7075-4-7 Atheroprotective natural anti-phosphorylcholine antibodies of igm subclass are decreased in swedish controls as compared to non-westernized individuals from new Guinea
Clin. Vaccine Immunol. Simell 15 1391 2008 10.1128/CVI.00110-08 Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins
Int. J. Clin. Rheumtol. Garcia-Carrasco 7 651 2012 10.2217/ijr.12.64 Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation
Sci Rep Gunti 5 15066 2015 10.1038/srep15066 Stimulation of toll-like receptors profoundly influences the titer of polyreactive antibodies in the circulation
Lupus Salaman 2017 10.1177/0961203317707826 The immunological personality of close relatives of SLE patients
Curr. Opin. Rheumatol. Chen 29 423 2017 10.1097/BOR.0000000000000411 Genetic advances in systemic lupus erythematosus: an update
Eur. J. Hum. Genet. Graham 15 823 2007 10.1038/sj.ejhg.5201827 Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human sle
Clin. Immunol. Rahman 166-167 27 2016 10.1016/j.clim.2016.04.007 IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: regulation and underlying mechanisms
Front. Immunol. Popi 7 138 2016 10.3389/fimmu.2016.00138 An overview of B-1 cells as antigen-presenting cells
HLA Sheen 88 25 2016 10.1111/tan.12851 Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model
Arthritis Res. Ther. Ambrosi 14 208 2012 10.1186/ar3787 Congenital heart block: evidence for a pathogenic role of maternal autoantibodies
Rheum. Dis. Clin. N. Am. Buyon 31 299 2005 10.1016/j.rdc.2005.01.010 Neonatal lupus: basic research and clinical perspectives
Arthritis Rheum. Zhuang 68 2917 2016 10.1002/art.39781 A novel mechanism for generating the interferon signature in lupus: Opsonization of dead cells by complement and igm
Clin. Exp. Immunol. Svenungsson 181 417 2015 10.1111/cei.12651 Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus
Curr. Opin. Rheumatol. Knight 25 597 2013 10.1097/BOR.0b013e328363eba3 Cardiovascular disease in lupus: insights and updates
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.